Reform is the main game for improvement, says AbbVie’s Chris Stemple

Pharma News: Chris Stemple, General Manager AbbVie ANZ and the new Deputy Chair of Medicines Australia Board joined Health Industry Hub in discussing why this is a pivotal year for the pharma industry.

A recent PwC survey of Australians revealed ‘health’ in the top three priorities for shaping their election vote. Yet, it has been a ‘steady as she goes’ Budget announcement for the innovative medicines industry.

Chris reflected on the current health policy landscape of promising reform opportunities highlighted by the release of recommendations from the Zimmerman Inquiry into Approval Processes for New Drugs and Novel Medical Technologies, the ongoing review of the National Medicines Policy (NMP), and the upcoming independent review of Health Technology Assessment (HTA).

Driving the necessary policy changes and thriving in the changing and complex healthcare landscape requires influential and inspirational leadership. Chris considered the relevance and impact of diversity, equity and inclusion in leadership at AbbVie. He also shared the key takeaways from the recent AusBiotech/Medicines Australia International Women’s Day event, as the only male panel member contributing to the panel discussion.

You may also like: Health Industry Hub’s Women in Leadership Series – empowering women in the Pharma, MedTech and Biotech sectors by celebrating and sharing the journey of inspirational and passionate leaders in the industry.